The 9 analysts offering 12-month price forecasts for Core Laboratories NV have a median target of 35.00, with a high estimate of 54.00 and a low estimate of 17.50. The median estimate represents a +20.48% increase from the last price of 29.05.
The current consensus among 12 polled investment analysts is to Hold stock in Core Laboratories NV. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.19
Reporting Date Oct 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.